Mirafuentes, Luzminda .

HRN: 26-28-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
CEFUROXIME 500MG (TAB)
11/28/2024
12/05/2024
ORAL
500mg
BID
S/P LSTCS + BTL
Waiting Final Action 
11/28/2024
MUPIROCIN 2%, 15G (TUBE)
11/28/2024
12/05/2024
TOPICAL
15g
BID
S/P LSTCS + BTL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: